Haida Nursing: Failed to Inform Family of Drug Risks - PA
Haida Nursing and Rehab increased Resident 5's daily Seroquel dose from 250 milligrams to 350 milligrams over two separate medication changes in May 2025. The antipsychotic drug treats agitation in dementia patients but carries significant side effects including sedation, movement disorders, and increased risk of death in elderly patients with dementia.
On May 15, 2025, staff called a certified physician's assistant with psychiatric services about the resident's increased agitation. The provider ordered an additional 50 milligrams of Seroquel twice daily, bringing the total daily dose to 350 milligrams. A physician's order dated May 27, 2025, specified two 25-milligram tablets twice daily "related to dementia with agitation."
Federal inspectors found no evidence in the resident's medical record that staff informed the family representative about the medication's risks, benefits, or alternative treatments before either dose increase. The regulation requires nursing homes to obtain informed consent from residents or their representatives before starting or significantly changing psychiatric medications.
A nursing note from May 27 at 2:11 p.m. documented that the psychiatric provider "was called and updated with the resident's increased agitation and a medication change was ordered." But the clinical record contained no documentation of discussions with the family about what the higher doses might accomplish or what problems they could cause.
The Director of Nursing confirmed during a September 4 interview that nursing notes from May 15 at 1:30 p.m. and May 27 at 2:13 p.m. indicated staff had notified the resident's representative about the Seroquel dosage changes. However, notification alone does not satisfy federal requirements.
The missing documentation represents more than paperwork. Seroquel and similar antipsychotic medications carry a black box warning from the Food and Drug Administration about increased mortality risk in elderly dementia patients. Common side effects include extreme drowsiness, dizziness, constipation, and movement problems that can persist even after stopping the medication.
Alternative approaches for managing dementia-related agitation include environmental modifications, structured activities, music therapy, and addressing underlying medical causes like pain or infection. Some residents and families choose these non-drug interventions over psychiatric medications, particularly given the serious risks involved.
The facility's failure occurred during a period when the resident's agitation was escalating enough to prompt two separate medication increases within twelve days. Staff documented calling the psychiatric provider and receiving new orders, but the clinical record showed no evidence of conversations with the family about whether they wanted to try the higher doses or preferred other approaches.
Federal regulations require nursing homes to ensure residents or their representatives receive sufficient information to make informed decisions about psychiatric medications. This includes explaining the medication's intended benefits, potential risks and side effects, and available alternatives before obtaining consent for treatment changes.
The inspection found the facility violated federal requirements for informed consent regarding psychiatric medications. The deficiency affected few residents but represented minimal harm or potential for actual harm, according to the Centers for Medicare and Medicaid Services severity rating.
Resident 5's case illustrates how documentation gaps can leave families uninformed about significant treatment decisions. While staff may have verbally notified the representative about the medication changes, the absence of documented informed consent discussions means there is no record that the family understood what they were agreeing to when the doses increased.
The May medication changes occurred as the resident's behavioral symptoms worsened, creating pressure on staff to find solutions quickly. But federal standards require nursing homes to balance urgent clinical needs with residents' rights to make informed treatment choices, even when family members serve as decision-makers for cognitively impaired residents.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Haida Nursing and Rehab from 2025-09-04 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
HAIDA NURSING AND REHAB in HASTINGS, PA was cited for violations during a health inspection on September 4, 2025.
Haida Nursing and Rehab increased Resident 5's daily Seroquel dose from 250 milligrams to 350 milligrams over two separate medication changes in May 2025.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.